The Scope of Things

Clinical Research News

The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News Senior Writer welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider’s look at clinical research today.

  1. Episode: 47 - Joseph Kim on Pragmatic Solutions to Age-Old Problems

    2D AGO

    Episode: 47 - Joseph Kim on Pragmatic Solutions to Age-Old Problems

    Joining this month’s episode of The Scope of Things is Joseph Kim, chief strategy officer of ProofPilot, who talks about his company’s first-ever CORE Symposium, where pharma pros shared practical solutions to age-old trial challenges. Kim provides a pragmatic viewpoint on the problematic trio of clinical trials—study execution, recruitment, and engagement—and what change agents are needed to pave the way forward and find an exit from the bottlenecks. Plus, host Deborah Borfitz delivers the latest on a planned mapping of clinical trial deserts, the high cost of accelerated FDA approvals, the best states for cancer research, the world’s first in-ear EEG system getting approved, and a new smartphone-based outcome measure for sleep studies.   News Roundup  Financial hurdles to trial enrollment  Study in the Journal of the National Comprehensive Cancer Network News on the Case Western Reserve University website  Accelerated cancer drug approvals  Study in BMJ Medicine Best states for cancer research  Blog on SmileHub website In-ear EEG devices  Article in Diagnostics World News Ecological momentary assessment in sleep-focused trial  Study in JAMA Network Open    Guest  Joseph Kim, chief strategy officer for ProofPilot  The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News senior writer, Deborah Borfitz, welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider’s look at clinical research today.

    25 min
  2. JAN 6

    Episode: 46 - Dan Drozd on How Noninterventional Studies Can Change the Clinical Research Game

    Noninterventional studies in clinical research are underutilized in clinical research and inefficient. Dan Drozd, CMO of PicnicHealth, knows we can do better. With host Deborah Borfitz, Drozd discusses the issues and ramifications researchers face from the lack of noninterventional studies, offers tactics for raising the bar for evidence generation, and shares what he expects in the clinical research space in 2026 in this episode of the Scope of Things. Plus, Borfitz shares the latest news on an expanding good pharma score card, an entirely telehealth-based cancer trial, a novel online platform for bowel cancer research, improving patient-reported outcomes in cancer trials, a virtual clinical trial for psychedelics, and identifying Type 1 diabetes in the symptom-less window stage. Show Notes     News Roundup  Good Pharma Scorecard  Study in JAMA Internal Medicine News on the Yale Scool of Medicine website  Nationwide telehealth trial for cancer  News on The Ohio State University website Online platform for bowel cancer research  News on the Newcastle University website Patient-reported outcomes in cancer clinical trials  Paper in The Lancet Oncology News on the European Organisation for Research and Treatment of Cancer website Virtual clinical trial of psychedelics  Research article in Advanced Science Type 1 diabetes risk prediction testing  Study in The Lancet News on the University of Exeter website Guest  Dan Drozd, M.D., CMO of PicnicHealth  The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News senior writer, Deborah Borfitz, welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider’s look at clinical research today.

    26 min
  3. Episode: 45 -  Doug Bain on Streamlining Clinical Trials

    12/02/2025

    Episode: 45 - Doug Bain on Streamlining Clinical Trials

    Doug Bain, founder and consulting partner of ClinFlo, discusses his proposed regulatory blueprint for digital trials in the latest episode of The Scope of Things podcast. With host Deborah Borfitz, Bain delves into his strategy for turning 21 CFR Part 11 into a more practical regulation that streamlines rather than bogs down clinical trials, what would qualify someone to take on the role as a trusted third party (and what makes them trustworthy), and the new FDA administration’s modernization plan aligns—or squares—with his ideas. Plus, the latest news on a tool for detecting fraud and sampling bias in decentralized trials, technology for identifying potentially dangerous drugs before trials start, a novel women’s health and menopause initiative, a regenerative therapy for spinal cord injury, and a new oral treatment for preventing dementia.  Show Notes :   News Roundup Data collection tools for decentralized trials  MyTrials platform study in the Journal of Clinical and Translational Science  Real-time data integration tool  Press release on the Mount Sinai website Drug toxicity prediction  Article in EbioMedicine  Tufts Women’s Health and Menopause Initiative  News from Tufts University  Regenerative therapy for spinal cord injury  Article in Nature Oral treatment for preventing dementia  Press release from Aarhus University  Guest  Doug Bain, founder and consulting partner of UK-based ClinFlo    The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News senior writer, Deborah Borfitz, welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider’s look at clinical research today.

    24 min
  4. Episode 44 - SCOPE Europe 2025 on AI Literacy Training, Reducing Excess Data Collection, Combating Superbugs

    11/04/2025

    Episode 44 - SCOPE Europe 2025 on AI Literacy Training, Reducing Excess Data Collection, Combating Superbugs

    This episode of the Scope of Things features an exclusive panel at SCOPE Europe 2025 covering regulatory requirements for AI literacy training, featuring industry executives Jonathan Crowther, head of the operational design center at Merck KGaA; Janie Hansen, global development information management, business systems transformation at Daiichi Sankyo; Francis Kendall, head of statistical programming, digital and data sciences at Biogen; and James Weatherall, vice president and chief data scientist of biopharmaceuticals R&D at AstraZeneca. Plus, host Deborah Borfitz gives the latest news on efforts to reduce excess data collection in studies, whole genome sequencing of breast cancer, a virus cocktail to combat superbugs, and more.  Show Notes News Roundup    Collaborative study on data collection in trials  News posted on the TransCelerate website Heart benefits of semaglutide  Study in The Lancet Whole genome sequencing of breast cancers  Study in The Lancet Oncology Pan-cancer immunotherapy heads to trials  Research article in Cell Article in Bio-IT World Promising NAD+ “youth molecule”  Review article in Nature Aging  Virus cocktail to combat superbugs  Article in Nature Microbiology AI annotates medical images  News posted on the MIT website Fitbits aid precision health  American Life in Realtime study in PNAS Nexus Latest from the Human Epilepsy Project  Study in JAMA Neurology Imposter study participants  Editorial in The BMJ Guests  Jonathan Crowther, Ph.D., Head, Operational Design Center, Merck KGaA, Darmstadt, Germany Janie Hansen, Global Development Information Management, Business Systems Transformation, Daiichi Sankyo Francis Kendall, Head of Statistical Programming, Digital and Data Sciences, Biogen James Weatherall, Ph.D., Vice President & Chief Data Scientist, BioPharmaceuticals R&D, AstraZeneca   The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News senior writer, Deborah Borfitz, welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider’s look at clinical research today.

    16 min
  5. Episode: 43 - Overcoming the Deadlock in Patient Recruitment With Christine Senn

    10/07/2025

    Episode: 43 - Overcoming the Deadlock in Patient Recruitment With Christine Senn

    For decades, clinical trial recruitment has been the biggest challenge in the industry. Christine Senn, senior vice president of Site-Sponsor Innovation at Advarra, offers insights into why the struggle continues, such as delays in getting regulations updated after a quarter of a century, and how to overcome the deadlock in clinical trial recruitment that is tied to current obsolete marketing guidelines. Also, host Deborah Borfitz shares the latest on beta blockers, low dose aspirin lowering the risk of recurring colorectal cancer, repurposing drugs for breast cancer relapse prevention, remote participation research on why athletes and military members face higher ALS risk, and the first agentic AI platform for life sciences from Medable.  Show Notes  News Roundup  Rethinking beta blockers  Press release on the Mount Sinai website Subgroup analysis study in the European Heart Journal Aspirin lowers risk of colorectal cancer recurrence  Study in The New England Journal of Medicine  CLEVER study to prevent breast cancer relapse  Study in Nature Medicine News release on Penn Medicine website   Champion Insights ALS initiative  News release on Answer ALS website Medable’s Agent Studio  Press release on the Medable website Disseminating research findings  Systematic review in PLOS Medicine  Guest  Christine Senn, Ph.D., senior vice president of site-sponsor innovation at Advarra  The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News senior writer, Deborah Borfitz, welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider’s look at clinical research today.

    24 min
  6. Episode: 42 - Myeloma Research on a Global Scale with Joseph Mikhael

    09/09/2025

    Episode: 42 - Myeloma Research on a Global Scale with Joseph Mikhael

    Joseph Mikhael, chief medical officer of The International Myeloma Foundation, and his organization are pulling all the stops to find a true cure for multiple myeloma, a rare and often fatal blood cancer. He shares the origins and mission of the Black Swan Research Initiative, a research project dedicated to preventing myeloma and finding a cure, and how global collaborators are contributing to multiple myeloma research. Also, host Deborah Borfitz delivers the latest news on ChatGPT determining trial eligibility, a questionable shortcut in rectal cancer drug trials, a new no-nausea weight loss remedy heading to trial, and more.  News Roundup  AI for stratifying Alzheimer’s patients  Study in Nature Communications  Questionable shortcut in rectal cancer drug trials  Investigation in JAMA Network Open ChatGPT determines trial eligibility  Paper in Machine Learning: Health Major trauma study to test hemorrhage treatment  News release by University of Colorado Anschutz Medical Campus New weight loss remedy soon heads to trials  News on Syracuse University website Study in Science Translational Medicine The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News senior writer, Deborah Borfitz, welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider’s look at clinical research today.

    28 min
  7. 08/05/2025

    Episode: 41 - How Non-Profits Are Filling Unique Roles in Clinical Research

    Children’s Tumor Foundation CEO Annette Bakker discusses what non-profit organizations uniquely bring to clinical research and new financial models sustaining their contribution. Plus, host Deborah Borfitz rounds up the latest news in clinical research: new funding approaches for ALS clinical trials, spatial biology to match patients to trials, a bio map of lung cancer tumor changes, improving diabetes treatment outcomes for patients in China, and more.   Show Notes  News Roundup    Fund of Adaptive Royalties  Research article in PLOS One TACIT algorithm matching patients to trials  Article in Nature Communications Mapping biomarkers linked to treatment resistance  Press release on the City of Hope website  Pragmatic diabetes trial in China  Paper about China-specific genetic risk score in Diabetologia News of trial launch on the University of Exeter website Cough medicine to slow dementia?  Study in JAMA Neurology Beating the EARL hurdles in the UK  Study in JAMA Network Open Guest  Annette Bakker, Ph.D., CEO of the Children's Tumor Foundation  Article in Clinical Research News  The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News senior writer, Deborah Borfitz, welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider’s look at clinical research today.

    35 min
  8. Episode 40: The Advancement and Implementation of Pragmatic Trials

    07/08/2025

    Episode 40: The Advancement and Implementation of Pragmatic Trials

    The latest on a trio of pragmatic trials for lung cancer treatment, the implementation of national-scale pharmacogenomic testing, an efficient approach to comparing commonly used intravenous fluids, improving access to gene therapy trials for a progressive heart condition, the landscape for Alzheimer’s disease studies, clinical trials that predict the most effective therapy, and the creation of AI agents for clinical research. Joining the discussion is Bethany Kwan, director of the Dissemination & Implementation Research Core at the Colorado Clinical & Translational Sciences Institute at the University of Colorado Anschutz Medical Campus, and Heather Smyth, research associate with the Center for Innovative Design and Analysis in the Colorado School of Public Health. They talk about the advancement of pragmatic clinical trials, how they differ from traditional studies, and how to handle the challenges that come with implementing them.    The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News senior writer, Deborah Borfitz, welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider’s look at clinical research today.

    28 min
5
out of 5
22 Ratings

About

The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News Senior Writer welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider’s look at clinical research today.